Home › Lung Cancer › NCT05171478

Full-Field Optical Coherence Tomography (FFOCT) for Evaluation of Bronchoscopic Small Biopsy Specimens

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Inpatients or outpatients greater than or equal to 18 years old
* Capable of providing informed consent
* Undergoing bronchoscopy for diagnosis or staging per standard of care
* Collection of small biopsy samples by EBUS or conventional transbronchial needle aspiration (TBNA) or transbronchial biopsy for purposes outside of the research study

Exclusion Criteria:

* Standard contraindications bronchoscopy including bleeding disorders, antiplatelet or anticoagulant usage, severe respiratory failure, and clinical instability
* Pregnancy

About the study

This study sets out to register imaging of small biopsy specimens obtained during bronchoscopy using full-field optical coherence tomography against standard histologic evaluation.

What is being tested

• Full-field optical coherence tomography (diagnostic test)

Sponsor: Johns Hopkins University · Participants: 20 · Started: Dec 9, 2021

Contact the study team

• Jeffrey Thiboutot, MD · Phone: 410-502-2533

Official record on ClinicalTrials.gov — NCT05171478

Locations in the U.S.

Conditions

• Lung Cancer
• Sarcoidosis

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.